Bracco, an Italy-based company that deals with diagnostic imaging, announced on Wednesday that it entered into a new long-term partnership with ulrich GmbH & Co. KG, a Germany-based medical device manufacturer specialising in contrast media injectors and spinal implants.
The collaboration is intended to bring a Bracco-branded MR injector to the United States under an exclusive private label arrangement. Both companies have also submitted a 510(k) premarket notification to the FDA for the new device manufactured by ulrich GmbH & Co. KG.
The injector submitted to the FDA is already approved by the European Medicines Agency and commercialized by ulrich medical in the European Union and in numerous other countries around the globe.
Fulvio Renoldi Bracco Imaging SpA, vice chairman & chief executive Officer, said, 'Through our strategic collaboration and this private label agreement with ulrich medical, Bracco will bring syringeless MR injectors to the U.S. and today's submission for 510(k) clearance to the FDA brings us one step closer to elevating the standard of diagnostic imaging solutions around the country to expand Bracco's MR portfolio in the U.S. We are taking bold actions to help make a difference for patients, and this long-term partnership serves as a testament to our commitment to improved quality and efficiency for healthcare providers.'
Johnson & Johnson agrees acquisition of V-Wave
Nightingale Health gains UKCA certification and expands with new laboratory
Talphera enrols first subject in NEPHRO CRRT study
China Pharma Holdings anticipates launch of Dry Eye Disease Therapeutic Device in early 2025
SOPHiA DDM Platform achieves IVDR certification, enhancing diagnostic precision
Medtronic reports FDA approval of Simplera CGM; partners with Abbott
OncoBeta expands Rhenium-SCT (Skin Cancer Therapy) treatment services in Italy
Labcorp's PGDx elio plasma focus Dx receives US FDA De Novo marketing authorisation
Verici Dx announces completion of Thermo Fisher Scientific licensing agreement
Polarean Imaging enters into trade-in agreement with University of Kansas Medical Center